Skip to main content

ADVERTISEMENT

Kami J. Maddocks, MD

Kami J. Maddocks, MD
Videos
09/05/2023
Kami J. Maddocks, MD, analyzes the updated results of the BRUIN trial on the efficacy and safety of pirtobrutinib among patients with high-risk heavily pretreated R/R mantle cell lymphoma with prior covalent BTK inhibitor therapy.
Kami J. Maddocks, MD, analyzes the updated results of the BRUIN trial on the efficacy and safety of pirtobrutinib among patients with high-risk heavily pretreated R/R mantle cell lymphoma with prior covalent BTK inhibitor therapy.
Kami J. Maddocks, MD, analyzes...
09/05/2023
Oncology
Expert Roundtable
Videos
11/03/2023
In the first part of an expert roundtable series, Kami Maddocks, MD, leads a discussion with Jia Ruan, MD, PhD, and Krish Patel, MD, on the diagnostics and risk stratification of mantle cell lymphoma.
In the first part of an expert roundtable series, Kami Maddocks, MD, leads a discussion with Jia Ruan, MD, PhD, and Krish Patel, MD, on the diagnostics and risk stratification of mantle cell lymphoma.
In the first part of an expert...
11/03/2023
Oncology
KOL Roundtable
Videos
11/13/2023
Kami Maddocks, MD, discusses the role of non-covalent BTK inhibitors in the treatment of patients with mantle cell lymphoma with Jia Ruan, MD, PhD, and Krish Patel, MD.
Kami Maddocks, MD, discusses the role of non-covalent BTK inhibitors in the treatment of patients with mantle cell lymphoma with Jia Ruan, MD, PhD, and Krish Patel, MD.
Kami Maddocks, MD, discusses the...
11/13/2023
Oncology
KOL Roundtab
Videos
11/13/2023
In this expert roundtable series, Kami Maddocks, MD, leads a discussion with Jia Ruan, MD, PhD, and Krish Patel, MD on the best options for treating patients with relapsed/refractory mantle cell lymphoma.
In this expert roundtable series, Kami Maddocks, MD, leads a discussion with Jia Ruan, MD, PhD, and Krish Patel, MD on the best options for treating patients with relapsed/refractory mantle cell lymphoma.
In this expert roundtable...
11/13/2023
Oncology
KOL Roundtable
Videos
11/09/2023
In the second part of an expert roundtable series, Kami Maddocks, MD, leads a discussion with Jia Ruan, MD, PhD, and Krish Patel, MD on goals and choice of frontline therapy for patients with mantle cell lymphoma.
In the second part of an expert roundtable series, Kami Maddocks, MD, leads a discussion with Jia Ruan, MD, PhD, and Krish Patel, MD on goals and choice of frontline therapy for patients with mantle cell lymphoma.
In the second part of an expert...
11/09/2023
Oncology
Kami J. Maddocks, MD
Videos
09/22/2023
Kami J. Maddocks, MD, discusses results from a single-arm study on the addition of venetoclax to a lenalidomide and rituximab regimen for patients with previously untreated mantle cell lymphoma.
Kami J. Maddocks, MD, discusses results from a single-arm study on the addition of venetoclax to a lenalidomide and rituximab regimen for patients with previously untreated mantle cell lymphoma.
Kami J. Maddocks, MD, discusses...
09/22/2023
Oncology